The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice

Obesity and obesity related kidney and liver disease have become more prevalent over the past few decades, especially in the western world. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic agents with promising effects on cardiovascular and renal function. Given SGLT...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Mol Sci
Huvudupphovsmän: Wang, Dong, Luo, Yuhuan, Wang, Xiaoxin, Orlicky, David J., Myakala, Komuraiah, Yang, Pengyuan, Levi, Moshe
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796086/
https://ncbi.nlm.nih.gov/pubmed/29301371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19010137
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk